Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NANOVIRICIDES, INC. Director's Dealing 2015

Jan 9, 2015

34915_dirs_2015-01-08_145e9ff2-41df-4e9a-916d-602c954b271e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOVIRICIDES, INC. (NNVC)
CIK: 0001379006
Period of Report: 2015-01-06

Reporting Person: BONIUK MILTON (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-12-04 Common Stock, par value $0.001 P 25000 $2.60 Acquired 1430391 Direct

Footnotes

F1: Includes 858,963 shares of Common Stock and warrants to purchase an additional 571,428 shares of Common Stock held by the Reporting Person and his wife. Does not include: 752,382 shares of Common Stock and warrants to purchase an additional 285,714 shares of Common Stock held by Boniuk Interests, Ltd.; 380,954 shares of Common Stock held by the Boniuk Charitable Foundation; or 952,381 shares of Common Stock issuable upon conversion of a 10% Coupon Series C Convertible Debenture or 187,000 shares of Series A Preferred Stock held by Milton Boniuk IRA, convertible into 654,500 shares of common stock, which are not readily convertible. Dr. Boniuk holds voting and dispositive power over the Boniuk Charitable Foundation, Boniuk Interests Ltd. and the Milton Boniuk IRA